Physician profile
Margaret E Wolf
NPI 1386638724
$1,683.82
in general payments reported to CMS, 2019-2025
20 companies · $441 in 2025
The $441 reported for 2025 was more than what 79% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $207 · 2022: $400 · 2023: $314 · 2024: $323 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,077.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $307.84 | 2021-2025 | |
| Pfizer INC. | $272.81 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $199.26 | 2022-2025 | |
| Astellas Pharma US INC | $192.55 | 2021-2025 | Veozah, Myrbetriq |
| Radius Health, INC. | $144.89 | 2025 | Tymlos |
| Exeltis, USA INC. | $85.23 | 2022-2025 | Slynd |
| Hologic Sales and Service, LLC | $83.60 | 2022-2025 | Acessa Provu System, Novasure, Aptima |
| Novo Nordisk INC | $74.74 | 2023-2025 | Wegovy |
| Amgen INC. | $64.42 | 2021-2025 | Evenity |
| Organon LLC | $57.55 | 2023-2024 | Nexplanon |
| Millicent US INC | $44.08 | 2025 | Femlyv, Intrarosa |
| Avion Pharmaceuticals | $24.19 | 2021-2022 | |
| Octapharma USA, INC. | $23.27 | 2025 | Fibryga |
| Merck Sharp & Dohme LLC | $18.85 | 2025 | Gardasil 9 |
| Smith+Nephew, INC. | $17.51 | 2024 | Pico 14, Pico 7, Renasys Touch |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $15.70 | 2022 | |
| Pharmacosmos Therapeutics INC. | $15.28 | 2023 | Monoferric |
| Myovant Sciences INC. | $15.17 | 2021 | |
| Exact Sciences Corporation | $14.36 | 2024 | Cologuard Collection Kit |
| Scynexis, INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Wolf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.